Just out! Interim analysis of the NivoILP trial. Nivo+ILP for #melanoma ITM found to be safe and of promising efficacy. Eagerly awaiting the full phase II results!!
Roger Olofsson Bagge Lars Ny Jonas Nilsson Yvonne Schrage et al. Sahlgrenska Academy & The Netherlands Cancer Institute

doi.org/10.1016/j.ejso…